Blog - Page 150 of 5433 - QualityStocks

WednesdayDec 04, 2024 8:45 am

Torr Metals Inc. (TSX.V: TMET) Distinguishing Itself: Driving New Exploration and Discovery in Canada’s Premier Mining Districts

In just over one year, Torr Metals has identified six undrilled gold anomalies covering a 1.2 x 2-kilometer (“km”) corridor, with gold soil grades up to 1.32 g/t Au along the Trans-Canada Highway; additional 2024 surface assays pending testing a highly prospective 7 km strike-length to potential mineralization At the 100% owned Kolos Copper-Gold Project, Torr’s inaugural soil sampling over the past year defined a 7 km porphyry trend with three undrilled copper-gold centers, boasting a footprint 33% larger than Copper Mountain Mine and double the average grades of regional deposits Investors can look forward to continued updates on upcoming…

WednesdayDec 04, 2024 8:00 am

Thumzup Media Corp. (NASDAQ: TZUP) Is ‘One to Watch’

Thumzup offers a unique platform designed to democratize the multi-billion-dollar social media marketing industry. The company combines programmatic advertising with user-generated content to create high-impact campaigns. Thumzup achieved 202% growth in advertisers on its platform through October 2024, showcasing strong traction. Recent video integration with Instagram Reels enhances platform capabilities and expands advertiser options. The company operates in a rapidly growing market with strong long-term growth potential, led by an experienced leadership team. Thumzup (NASDAQ: TZUP) is at the forefront of modernizing the social media branding and marketing industry with its unique platform designed to connect advertisers directly with everyday…

WednesdayDec 04, 2024 1:10 am

QualityStocksNewsBreaks – Meta Platforms Inc. (NASDAQ: META) Navigating Political Landscapes and Market Dynamics

Meta (NASDAQ: META) is a leading technology company known for its social media platforms, including Facebook, Instagram and WhatsApp. The company is at the forefront of digital communication and virtual reality innovation. Meta competes with other tech giants like Google, Apple and Amazon in various sectors, including advertising, hardware and software development. CEO Mark Zuckerberg’s potential involvement in shaping tech policies under a possible Trump administration could have significant implications for the industry. As highlighted by Jason Miller, discussions are ongoing about various political issues, which could impact regulatory frameworks. This involvement may influence how technology companies operate and innovate…

TuesdayDec 03, 2024 3:56 pm

QualityStocksNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Showcases Platform ‘Designed to Unlock New Possibilities in Cancer Therapy’

Calidi Biotherapeutics (NYSE American: CLDI) is focused on discovering more effective treatments amid projections from the American Cancer Society that 2024 will be the first year ever to see two million people diagnosed with cancer. “Calidi Biotherapeutics’ RTNova (‘CLD-400’) is an innovative systemic antitumor enveloped virotherapy designed to unlock new possibilities in cancer therapy. The platform addresses challenges presented by untargetable and untreatable metastatic diseases and offers a possible potential transformative solution with wide-ranging applications,” reads a recent article. “The company shared key information about RTNova at two recent conferences: the International Oncolytic Virotherapy Conference (‘IOVC’) in Rotterdam, Netherlands, which…

TuesdayDec 03, 2024 2:30 pm

Adageis Is ‘One to Watch’

Adageis operates in the rapidly expanding AI healthcare market, projected by Fortune Business Insights to reach $490.96 billion by 2032. The ProActive Care Platform offers seamless integration with existing EMR systems, reducing adoption barriers for healthcare providers. Partnerships with prominent organizations, such as HealthyU Clinics, and its status as an AthenaHealth marketplace partner, demonstrate Adageis’ growing influence in the healthcare sector. The company’s AI-driven predictive analytics enhance patient care and operational efficiency, aligning with the industry’s shift toward value-based care models. Led by a seasoned leadership team with extensive experience in healthcare and technology, Adageis is well-equipped to navigate the…

TuesdayDec 03, 2024 2:05 pm

QualityStocksNewsBreaks – Trump Media & Technology Group Corp. (NASDAQ: DJT) CEO Applauds Kash Patel’s FBI Nomination: ‘A Light to Restore Trust in the Bureau’

Trump Media & Technology Group (NASDAQ: DJT) is making headlines with its CEO, Devin Nunes, congratulating board member Kash Patel on his nomination as FBI Director by President-elect Trump. Nunes commends Patel’s legal and investigative skills, emphasizing his commitment to the Constitution and his efforts to uncover alleged misconduct in the Intelligence Community. TMTG is recognized for its platforms like Truth Social and Truth+, which focus on free speech and family-friendly content. The stock for DJT is currently priced at $32.95, marking a 1.42% increase, or $0.46. This reflects investor interest possibly influenced by the recent news of Patel’s nomination.…

TuesdayDec 03, 2024 9:30 am

QualityStocksNewsBreaks – Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) Boosts Production with Successful Tubing Operation at SASB Gas Field

Trillion Energy (CSE: TCF) (OTCQB: TRLEF) has completed the installation of 2 3/8 velocity string tubing in four wells at the SASB Gas Field in Turkey, including three long-reach wells on the Akcakoca Platform. This operation aims to reduce water loading and enhance gas production by enabling wells to produce at lower wellhead pressures. Initial results show steady production improvements from Guluc-2 and West Akcakoca-1, while Akcakoca-3 continues with reduced water output. The next phase includes similar upgrades to two tripod wells, reservoir stimulation, and optimized choke adjustments to maximize gas recovery. Despite winter delays, Trillion anticipates a significant boost…

TuesdayDec 03, 2024 9:00 am

QualityStocksNewsBreaks – Thumzup Media Corp. (NASDAQ: TZUP) Announces Integration with X Corp. to Revolutionize Digital Advertising

Thumzup Media Corp. (NASDAQ: TZUP) plans to integrate its innovative ad tech platform with X Corp. (formerly Twitter), expanding its reach to over 535 million monthly active users. This integration, expected by January 2025, complements Thumzup's existing presence on Instagram, allowing unified campaign management, enhanced audience targeting, and user monetization through authentic brand endorsements. CEO Robert Steele highlighted the milestone as part of Thumzup’s aggressive growth strategy following its Nasdaq listing and $250,000 in user payouts for 25,000 Instagram posts. The integration will enable Thumzup to explore diverse advertising content unique to X, driving scalable, authentic engagement in the booming…

TuesdayDec 03, 2024 8:45 am

D-Wave Quantum Inc. (NYSE: QBTS) Completes Q3 2024 with Key Product Milestones, New Partnerships and Technological Breakthroughs

Among the most notable technical achievements was the completion of the calibration of a 4,400 qubit Advantage2(TM) processor, capable of solving much larger and complex problems with faster time-to-solution than earlier generation processors. D-Wave earned “awardable” status on the U.S. Department of Defense’s Tradewinds buying platform, gaining increased visibility with U.S. government customers. New partnerships and collaborations include working with NTT DOCOMO, Japan Tobacco Inc., Staque and the Chicago Quantum Exchange. D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, recently announced Q3 2024 business results, highlighting…

TuesdayDec 03, 2024 8:00 am

Annovis Bio Inc. (NYSE: ANVS) to Present Recent Achievements and 2025 Strategic Outlook During Upcoming Live Investor Webcast

The webcast led by Annovis’ Founder, President and CEO, Maria Maccecchini, Ph.D., will take place on Dec. 11, at 4:30 p.m. EST. Dr. Maccecchini will provide a comprehensive view of the company’s recent achievements along with strategic initiatives for 2025, followed by a Q&A session. The company recently received FDA clearance to proceed with a pivotal Phase 3 Alzheimer’s disease program for lead drug candidate buntanetap, set to begin in early 2025. Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), will hold a…

Site Search

Company Search